Page 49 - Read Online
P. 49

Page 14 of 20                                                Singh et al. Cancer Drug Resist. 2025;8:56





               biomarker qualification pathway for circRNAs while ensuring compliance with clinical and ethical
               standards [130] . In summary, advancing the field of circRNAs in liquid biopsy requires a multidisciplinary
               strategy that integrates molecular biology, bioinformatics, clinical oncology, and regulatory science. With
               sustained research investment and a strong translational focus, circRNAs hold the promise to transform
               non-invasive cancer monitoring and the precision management of therapeutic resistance.


               CONCLUSION
               Combining liquid biopsy with circRNA research is a revolutionary way to monitor drug resistance in cancer.
               circRNAs have a covalently closed-loop structure, making them highly stable in circulation and ideal
               candidates for non-invasive biomarkers in real-time disease monitoring. Advances in molecular testing such
               as qRT-PCR, ddPCR, and RNA seq have provided adequate sensitivity and specificity to detect circRNA
               from plasma, serum, and exosomes. In this way, circRNA can be linked to specific resistance mechanisms
               that include the regulation of apoptosis, autophagy, epithelial–mesenchymal transition, and drug efflux. By
               assessing therapeutic responses, circRNA-based liquid biopsy can capture molecular changes, enabling
               real-time interpretation of these dynamic events. Beyond this analytical purpose, liquid biopsy with
               circRNAs can guide treatment decisions, enable early detection of resistance, and improve personalized
               cancer care. Further standardization and clinical validation of such approaches are needed; nonetheless,
               current evidence supports the potential of circulating circRNAs as future clinical tools in precision oncology.


               DECLARATIONS
               Acknowledgments
               The authors thank B​i​o​R​e​n​d​e​r​.​c​o​m​ (July 17, 2025) for assistance with graphics. Singh DD acknowledges
               support from DST-FIST-AIMT and DST-PURSE at Amity University, Rajasthan, India. The graphical
               abstract was created with B​i​o​R​e​n​d​e​r​.​c​o​m​ [Created in BioRender. Singh DD (2025)].


               Authors’ contributions
               Conceptualization, investigation, writing - original draft, review and editing: Singh DD
               Conceptualization, investigation, writing - original draft, review and editing: Yadav DK
               Supervision, resources, review and editing: Shin D
               All authors have read and approved the final manuscript.


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               This study was funded by the National Research Foundation of Korea (grant numbers: RS-2020-NR049589
               and RS-2025-00555975). This work was also supported by the Gachon University Research Fund of 2022
               (GCU-202206050001).

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2025.



                                                           42
   44   45   46   47   48   49   50   51   52   53   54